Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis
Authors:
- Zoe E BetteridgeZBZoe E Betteridge
- Neil J McHughNMNeil J McHugh
- 1 November 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 20 (6) , 675-680
Abstract
There is increasing evidence that patients with polymyositis and dermatomyositis have specific clinico-serological profiles. Myositis-specific autoantibodies target intracellular proteins involved in key processes such as translocation and nuclear transcription, and are closely linked to patterns of disease expression. This review highlights the recent work on novel myositis-specific autoantibodies, their autoantigen targets, the relationship to clinical subsets and potential role in pathogenesis. During the annual review period novel autoantibodies have been described in adult-onset dermatomyositis (anti-SAE autoantibodies) and juvenile dermatomyositis (anti-p155/140 autoantibodies) (anti-MJ or anti-p140 autoantibodies). These findings are important because the function of the autoantigen targets may point to shared pathogenic pathways. Studies highlighting the potential role of autoantigen-driven responses and autoantibody production in disease initiation and propagation are discussed, as well as further evidence on the relationship between autoantigens and corresponding target tissues. Considerable progress has been made emphasizing the striking association between genotype, serotype and clinical phenotype in the myositis disease spectrum. Further characterization of the identity and function of autoantigen systems in target tissues will greatly facilitate investigation of models of autoimmunity in this disease.Keywords
This publication has 39 references indexed in Scilit:
- Mechanisms of Disease: autoantigens as clues to the pathogenesis of myositisNature Clinical Practice Rheumatology, 2008
- Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significanceCurrent Opinion in Rheumatology, 2007
- The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositisAnnals of the Rheumatic Diseases, 2007
- Identification of a novel autoantibody directed against small ubiquitin‐like modifier activating enzyme in dermatomyositisArthritis & Rheumatism, 2007
- Anti-signal recognition particle autoantibodies: marker of a necrotising myopathyAnnals of the Rheumatic Diseases, 2006
- SUMO Modification Enhances p66-Mediated Transcriptional Repression of the Mi-2/NuRD ComplexMolecular and Cellular Biology, 2006
- Opioid use by patients in an orthopedics spine clinicArthritis & Rheumatism, 2005
- SUMO protein modificationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- The Newly Identified Human Nuclear Protein NXP-2 Possesses Three Distinct Domains, the Nuclear Matrix-binding, RNA-binding, and Coiled-coil DomainsJournal of Biological Chemistry, 2002
- Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.Journal of Clinical Investigation, 1993